BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31739793)

  • 1. Comparison and characterization of enriched mesenchymal stem cells obtained by the repeated filtration of autologous bone marrow through porous biomaterials.
    Chu W; Zhuang Y; Gan Y; Wang X; Tang T; Dai K
    J Transl Med; 2019 Nov; 17(1):377. PubMed ID: 31739793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion.
    Gan Y; Dai K; Zhang P; Tang T; Zhu Z; Lu J
    Biomaterials; 2008 Oct; 29(29):3973-82. PubMed ID: 18639333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells and porous β-tricalcium phosphate composites prepared through stem cell screen-enrich-combine(-biomaterials) circulating system for the repair of critical size bone defects in goat tibia.
    Chu W; Gan Y; Zhuang Y; Wang X; Zhao J; Tang T; Dai K
    Stem Cell Res Ther; 2018 Jun; 9(1):157. PubMed ID: 29895312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of 3D printed porous architecture on mesenchymal stem cell enrichment and differentiation.
    Ferlin KM; Prendergast ME; Miller ML; Kaplan DS; Fisher JP
    Acta Biomater; 2016 Mar; 32():161-169. PubMed ID: 26773464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Mesenchymal Stem Cell-Enriched β-Tricalcium Phosphate Scaffold Processed by the Screen-Enrich-Combine Circulating System Promotes Regeneration of Diaphyseal Bone Non-Union.
    Wang X; Chu W; Zhuang Y; Shi D; Tao H; Jin C; Dai K; Zhao J; Gan Y
    Cell Transplant; 2019 Feb; 28(2):212-223. PubMed ID: 30554525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17β-estradiol improves the efficacy of exploited autologous bone marrow-derived mesenchymal stem cells in non-union radial defect healing: A rabbit model.
    Zamani Mazdeh D; Mirshokraei P; Emami M; Mirshahi A; Karimi I
    Res Vet Sci; 2018 Jun; 118():11-18. PubMed ID: 29334646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential in vitro and in vivo responses of bone marrow stromal cells on novel porous gelatin-alginate scaffolds.
    Yang C; Frei H; Rossi FM; Burt HM
    J Tissue Eng Regen Med; 2009 Dec; 3(8):601-14. PubMed ID: 19685485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.
    Xu L; Liu Y; Sun Y; Wang B; Xiong Y; Lin W; Wei Q; Wang H; He W; Wang B; Li G
    Stem Cell Res Ther; 2017 Dec; 8(1):275. PubMed ID: 29208029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone healing capacity in patients undergoing total hip arthroplasty].
    Kučera T; Soukup T; Krs O; Urban K; Sponer P
    Acta Chir Orthop Traumatol Cech; 2012; 79(1):52-8. PubMed ID: 22405550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
    Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
    Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats.
    Cao L; Liu G; Gan Y; Fan Q; Yang F; Zhang X; Tang T; Dai K
    Biomaterials; 2012 Jul; 33(20):5076-84. PubMed ID: 22504017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production.
    Trivedi A; Miyazawa B; Gibb S; Valanoski K; Vivona L; Lin M; Potter D; Stone M; Norris PJ; Murphy J; Smith S; Schreiber M; Pati S
    J Transl Med; 2019 Apr; 17(1):128. PubMed ID: 30995929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIA fractions contain mesenchymal stroma cells with high osteogenic potency.
    Kuehlfluck P; Moghaddam A; Helbig L; Child C; Wildemann B; Schmidmaier G;
    Injury; 2015 Dec; 46 Suppl 8():S23-32. PubMed ID: 26747914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of allogeneic platelet lysate on equine bone marrow derived mesenchymal stem cell characteristics, including immunogenic and immunomodulatory gene expression profile.
    Yaneselli K; Barrachina L; Remacha AR; Algorta A; Vitoria A; Cequier A; Romero A; Vázquez FJ; Maisonnave J; Rodellar C
    Vet Immunol Immunopathol; 2019 Nov; 217():109944. PubMed ID: 31563725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culture and differentiation of osteoblasts on coral scaffold from human bone marrow mesenchymal stem cells.
    Tran CT; Gargiulo C; Thao HD; Tuan HM; Filgueira L; Michael Strong D
    Cell Tissue Bank; 2011 Nov; 12(4):247-61. PubMed ID: 20703817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cytotherapy device for rapid screening, enriching and combining mesenchymal stem cells into a biomaterial for promoting bone regeneration.
    Zhuang Y; Gan Y; Shi D; Zhao J; Tang T; Dai K
    Sci Rep; 2017 Nov; 7(1):15463. PubMed ID: 29133959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.
    Sun Y; Chen L; Hou XG; Hou WK; Dong JJ; Sun L; Tang KX; Wang B; Song J; Li H; Wang KX
    Chin Med J (Engl); 2007 May; 120(9):771-6. PubMed ID: 17531117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].
    Huang K; Zhou DH; Huang SL; Liang SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1049-53. PubMed ID: 16403278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.